Atheromatosis of the thoracic aorta and risk of stroke;Aterosclerosi dell'aorta toracica e rischio di ictus

Giornale Italiano di Cardiologia

Volumn 7, Issue 5, 2006, Pages 309-316

  Casella, Gianni ^a   Greco, Cristiano ^a   Perugini, Enrica ^a   Pallotti, Maria Giovanna ^a   Pavesi, Pier Camillo ^a   Di Pasquale, Giuseppe ^a  

^a MAGGIORE HOSPITAL   (Italy)

Author keywords

Atheroma; Prognosis; Therapy; Transesophageal echocardiography

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; WARFARIN; ANTICOAGULANT AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; DRUG DERIVATIVE; FIBRINOLYTIC AGENT; TICLOPIDINE;

AORTA ATHEROSCLEROSIS; BRAIN ISCHEMIA; CAROTID ARTERY OBSTRUCTION; CEREBROVASCULAR ACCIDENT; CORRELATION ANALYSIS; DISEASE SEVERITY; EVIDENCE BASED MEDICINE; HEART ATRIUM FIBRILLATION; HUMAN; IMAGING SYSTEM; MEDICAL DECISION MAKING; MEDICAL RESEARCH; PATIENT CARE; PROGNOSIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; THORACIC AORTA; THROMBOEMBOLISM; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT OUTCOME; AORTA DISEASE; ATHEROSCLEROSIS; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; ECHOGRAPHY; FOLLOW UP; META ANALYSIS; RECURRENT DISEASE; RISK; TIME;

ANTICOAGULANTS; ANTILIPEMIC AGENTS; AORTA, THORACIC; AORTIC DISEASES; ASPIRIN; ATHEROSCLEROSIS; CEREBROVASCULAR ACCIDENT; CONTROLLED CLINICAL TRIALS; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HUMANS; META-ANALYSIS; ODDS RATIO; PLATELET AGGREGATION INHIBITORS; PROGNOSIS; RECURRENCE; RISK FACTORS; TICLOPIDINE; TIME FACTORS; WARFARIN;

EID: 33745260440     PISSN: 18276806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. Wolf PA, D'Agostino RB, Belanger AJ, Kannel WB. Probability of stroke: a risk profile from the Framingham study. Stroke 1991; 22: 312-8.
2. Pearson TA, Blair SN, Daniels SR, et al, for the Population Science Committee of the American Heart Association. AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update. Consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. Circulation 2002; 106: 388-91.
3. Stone DA, Hawke MW, LaMonte M, et al. Ulcerated atherosclerotic plaques in the thoracic aorta are associated with cryptogenic stroke: a multiplane transesophageal echocardiographic study. Am Heart J 1995; 130: 105-8.
4. Amarenco P, Cohen A, Tzourio C, et al. Atherosclerotic disease of the aortic arch and the risk of ischemic stroke. N Engl J Med 1994; 331: 1474-9.
5. Mcleod MR, Amarenco P, Davis SM, Dorman GA. Atheroma of the aortic arch: an important and poorly recognised factor in the aetiology of stroke. Lancet Neurol 2004; 3: 408-14.
6. The French Study of Aortic Plaques in Stroke Group. Atherosclerotic disease of the aortic arch as a risk factor for recurrent ischemic stroke. N Engl J Med 1996; 334: 1216-21.
7. Fujimoto S, Yasaka M, Otsubo R, Oe H, Nagatsuka K, Minematsu K. Aortic arch atherosclerotic lesions and the recurrence of ischemic stroke. Stroke 2004; 35: 1426-9.
8. Tunick PA, Nayar AC, Goodkin GM, et al, for the NYU Atheroma Group. Effect of treatment on the incidence of stroke and other emboli in 519 patients with severe thoracic aortic plaque. Am J Cardiol 2002; 90: 1320-5.
9. Agmon Y, Khandheria BK, Meissner I, et al. Relation of coronary artery disease and cerebrovascular disease with atherosclerosis of the thoracic aorta in the general population. Am J Cardiol 2002; 89: 262-7.
10. Amarenco P, Duyckaerts C, Tzourio C, Hénin D, Bousser MG, Hauw JJ. The prevalence of ulcerated plaques in the aortic arch in patients with stroke. N Engl J Med 1992; 326: 221-5.
11. Gardner TJ, Horrieffer PJ, Manotio TA, et al. Stroke following coronary artery bypass grafting: a ten-year study. Ann Thorac Surg 1985; 40: 574-81.
12. Di Pasquale G, Pozzati A. Heart disease and stroke. In: Fieschi C, Fisher M, eds. Prevention of ischemic stroke. London: Martin Dunitz, 2000: 27-50.
13. De Simone N, Sassone B, Vinelli S, Pancaldi LG, Di Pasquale G. Stroke non emorragico, di possibile origine ateroembolica, in corso di infarto miocardico acuto trattato con trombolisi. Ital Heart J Suppl 2002; 3: 344-8.
14. Nihoyannopoulos P, Joshi J, Athanasopoulos G, Oakley CM. Detection of atherosclerotic lesions in the aorta by transesophageal echocardiography. Am J Cardiol 1993; 71: 1208-12.
15. Montgomery DH, Ververis JJ, McGorisk G, Frohwein S, Martin RP, Taylor WR. Natural history of severe atheromatous disease of the thoracic aorta: a transesophageal echocardiographic study. J Am Coll Cardiol 1996; 27: 95-101.
16. Amarenco P, Cohen A, Baudrimont M, Bousser MG. Transesophageal echocardiographic detection of aortic arch disease in patients with cerebral infarction. Stroke 1992; 23: 1005-9.
17. Horowitz DR, Tuhrim S, Budd J, Goldman ME. Aortic plaque in patients with brain ischemia: diagnosis by transesophageal echocardiography. Neurology 1992; 42: 1602-4.
18. Toyoda K, Yasaka M, Nagata S, Yamaguchi T. Aortogenic embolic stroke: a transesophageal echocardiographic approach. Stroke 1992; 23: 1056-61.
19. Tunick PA, Perez JL, Kronzon I. Protruding atheromas in the thoracic aorta and systemic embolization. Ann Intern Med 1991; 115: 423-7.
20. Jones EF, Kalman JM, Calafiore P, Tonkin AM, Dorman GA. Proximal aortic atheroma. An independent risk factor for cerebral ischernia. Stroke 1995; 26: 218-24.
21. Di Tullio MR, Sacco RL, Gersony D, et a]. Aortic atheromas and acute ischemic stroke: a transesophageal echocardiographic study in an ethnically mixed population. Neurology 1996; 46: 1560-6.
22. Ferrari E, Vidal R, Chevallier T, Baudouy M. Atherosclerosis of the thoracic aorta and aorta debris as a marker of poor prognosis: benefit of oral anticoagulants. J Am Coll Cardiol 1999; 33: 1317-22.
23. Tunick PA, Nayar AC, Goodkin GM, et al. Effect of treatment on the incidence of stroke and other emboli in 519 patients with severe thoracic aortic plaque. Am J Cardiol 2002; 90: 1320-5.
24. Tenenbaum A, Garniek A, Shemesh J, et al. Spiral computerized tomography (dual helical mode) as a detector of aortic atheromas in patients with stroke and systemic emboli: additional benefit of the contrast-enhanced technique. IMAJ 2000; 2: 1-5.
25. Kutz SM, Lee VS, Tunick PA, Krinsky GA, Kronzon I. Atheromas of the thoracic aorta: a comparison of transesophageal echocardiography and breath-hold gadoliniumenhanced 3D magnetic resonance angiography. J Am Soc Echocardiogr 1999; 12: 853-8.
26. Kronzon I. Protruding aortic atheroma: is there a need for a new imaging modality? IMAJ 2000; 2: 54-5.
27. Tenenbaum A, Motro M, Feinberg MS, et al. Retrograde flow in the thoracic aorta in patients with systemic emboli: a transesophageal echocardiographic evaluation of mobile plaque motion. Chest 2000; 118: 1703-8.
28. Otsubo R, Yasaka M, Nagatsuka K, Minematsu K, Yamaguchi T. The role of the aortic arch atherosclerosis in embolic stroke. (abstr) Stroke 1998; 29: 308.
29. Mendel T, Pasierski T, Szwed H, Baranska-Gieruszczak M, Czlonkowska A. Transesophageal echocardiographic findings in patients with anterior and posterior circulation infarcts. Acta Neurol Scand 1998; 97: 63-7.
30. Meissner I, Khandheria BK, Sheps SG, et al. Atherosclerosis of the aorta: risk factor, risk marker, or innocent bystander? A prospective population-based transesophageal echocardiography study. J Am Coll Cardiol 2004; 44: 1018-24.
31. Meissner I, Whisnant JP, Khandheria BK, et al. Prevalence of potential risk factors for stroke assessed by transesophageal echocardiography and carotid ultrasonography: the SPARC study. Stroke Prevention: Assessment of Risk in a Community. Mayo Clin Proc 1999; 74: 862-9.
32. Blackshear JL, Pearce LA, Hart RG, et al, for the Stroke Prevention in Atrial Fibrillation Investigators. Aortic plaque in atrial fibrillation: prevalence, predictors, and thromboembolic implications. Stroke 1999; 30: 834-40.
33. Agmon Y, Khandheria BK, Meissner I, et al. Independent association of high blood pressure and aortic atherosclerosis: a population-based study. Circulation 2000; 102: 2087-93.
34. Sen S, Oppenheimer SM, Lima J, Cohen B. Risk factors for progression of aortic atheroma in stroke and transient ischemic attack patients. Stroke 2002; 33: 930-5.
35. Coppola A, Davi G, De Stefano V, Mancini FP, Cerbone AM, Di Minno G. Homocysteine, coagulation, platelet function, and thrombosis. Semin Thromb Hemost 2000; 26: 243-54.
36. Geraci A, Weinberger J. Natural history of aortic arch atherosclerotic plaque. Neurology 2000; 54: 749-51.
37. Di Pasquale G, Biancoli S, Urbinati S, Pinelli G, Pancaldi LG, Sassone B. Nuovi orientamenti su quando correggere le stenosi carotidee in pazienti candidati a bypass aortocoronarico. In: Rovelli F, De Vita C, Moreo A, eds. Cardiologia 1997. Atti del XXI Corso di Aggiornamento Centro A De Gasperis. Milano: Scientific Press, 1997: 755-67.
38. Sheikhzadeh A, Ehlermann P. Atheromatous disease of the thoracic aorta and systemic embolism. Clinical picture and therapeutic challenge. Z Kardiol 2004; 93: 10-7.
39. Sharony R, Bizekis CS, Kanchuger M, et al. Off-pump coronary artery bypass grafting reduces mortality and stroke in patients with atheromatous aortas: a case control study. Circulation 2003; 108: 1115-1120.
40. Davila-Roman VG, Phillips KJ, Daily BB, Davila RM, Kouchoukos NT, Barzilai B. Intraoperative transesophageal echocardiography and epiaortic ultrasound for assessment of atherosclerosis of the thoracic aorta. J Am Coll Cardiol 1996; 28: 942-7.
41. Tunick PA, Rosenzweig BP, Katz ES, Freedberg RS, Perez JL, Kronzon I. High risk for vascular events in patients with protruding aortic atheromas: a prospective study. J Am Coll Cardiol 1994; 23: 1085-90.
42. Mitusch R, Doherty C, Wucherpfennig H, et al. Vascular events during follow-up in patients with aortic arch atherosclerosis. Stroke 1997; 28: 36-9.
43. The Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography. TEE correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation. Ann Intern Med 1998; 128: 639-47.
44. Kazui S, Levi CR, Jones EF, Quang L, Calafiore P, Donnan GA. Lacunar stroke: transoesophageal echocardiographic factors influencing long-term prognosis. Cerebrovasc Dis 2001; 12: 325-30.
45. Dressler FA, Craig VVR, Castello R, Labovitz AJ. Mobile aortic atheroma and systemic emboli: efficacy of anticoagulation and influence of plaque morphology on recurrent stroke. J Am Coll Cardiol 1998; 31: 134-8.
46. Willens HJ, Kramer HJ, Kessler KM. Transesophageal echocardiographic findings in blue toe syndrome exacerbated by anticoagulation. J Am Soc Echocardiogr 1996; 9: 882-4.
47. Aortic Arch Related Cerebral Hazard Trial Website. The ARCH trial, study design. http://www.strokeresearch.com.au/arch.htm (accessed August 24, 2005).
48. Vaduganathan P, Ewton A, Nagueh SF, Weilbaecher DG, Safi HJ, Zoghbi WA. Pathologic correlates of aortic plaques, thrombi and mobile "aortic debris" imaged in vivo with TEE. J Am Coll Cardiol 1997; 30: 357-63.
49. Bucher HC, Griffith LE, Guyatt GH. Effect of HMGcoA reductase inhibitors on stroke. A meta-analysis of randomized, controlled trials. Ann Intern Med 1998; 128: 89-95.
50. Plehn JF, Davis BR, Sacks FM, et al. Reduction of stroke incidence after myocardial infarction with pravastatin: the Cholesterol and Recurrent Events (CARE) study. Circulation 1999; 99: 216-23.
51. Herrera CJ, Frazin LJ, Dau PC, et al. Atherosclerotic plaque evolution in the descending thoracic aorta in familial hyper-cholesterolemic patients. A transesophageal echo study. Arterioscler Thromb 1994; 14: 1723-9.
52. Davies MJ, Richardson PD, Woolf N, Katz DR, Mann J. Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. Br Heart J 1993; 69: 377-81.
53. Cohen A, Tzourio C, Bertrand B, Chauvel C, Bousser MG, Amarenco P, on behalf of the FAPS Investigators. Aortic plaque morphology and vascular events. A follow-up study in patients with ischemic stroke. Circulation 1997; 96: 3837-41.
54. Renshaw A, McCowen T, Waltke EA, et al. Angioplasty with stenting is effective in treating blue toe syndrome. Vasc Endovascular Surg 2002; 36: 155-9.
55. Toso V, Coccheri S, Di Pasquale G, et al. Prevenzione secondaria. Stroke Prevention and Educational Awareness Diffusion (SPREAD). Ictus cerebrale: linee guida italiane di prevenzione e trattamento. Milano: Catel, 2003: 253-70.